Business News

MarathonPharmaPresser

Launch of Emflaza, $89,000-A-Year Muscular Dystrophy Drug, Has Been 'Paused' Amid Public Outcry

Marathon Pharmaceuticals' newly approved drug is now on hold after patient advocates and policymakers criticized its expensive price.

02_09_walmart_01

3 Companies That Could Suffer From a Trump Trade War With Mexico

The president has discussed imposing a protective tariff of 20 percent on imports from Mexico.